Steve Krognes

Steve Krognes

Director/Board Member presso DENALI THERAPEUTICS INC.

Patrimonio netto: 19 M $ in data 31/03/2024

56 anni
Health Technology
Commercial Services
Consumer Services

Provenienza dei contatti di primo grado di Steve Krognes

EntitàTipo di entitàSettore Industriale
The Wharton School of the University of Pennsylvania
370
College/University Other Consumer Services 370
Harvard Business School
270
College/University Other Consumer Services 270
116
Subsidiary Biotechnology 116
Public Company Biotechnology 26
Public Company Medical/Nursing Services 26
Public Company Pharmaceuticals: Other 20
Public Company Biotechnology 19
Public Company Pharmaceuticals: Major 17
Public Company Pharmaceuticals: Major 12
7
Non-Profit Organization Miscellaneous Commercial Services 7
Public Company Biotechnology 6
5
Non-Profit Organization Miscellaneous Commercial Services 5
Public Company Major Banks 3
Genentech Access To Care Foundation
1
Private Company 1

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Steve Krognes tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Vicki Sato

Myrtle Potter

Erik Harris

Director/Board Member

Corporate Officer/Principal

Sales & Marketing

PFIZER, INC. Pharmaceuticals: Major

Marc Tessier-Lavigne

Craig Eagle

Karin Jooss

Karl Gubitz

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

REGENERON PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Schenkein

Marc Tessier-Lavigne

Director/Board Member

Director/Board Member

VERTEX PHARMACEUTICALS INCORPORATED Pharmaceuticals: Major

Vicki Sato

Nancy Thornberry

President

Director/Board Member

Pharmaceuticals: Major

David Schenkein

Clare Fisher

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Pius Baschera

Bruno Gehrig

Beatrice Weder di Mauro

Severin Schwan

Director/Board Member

Director/Board Member

Director/Board Member

Chief Executive Officer

INTERMUNE INC Biotechnology

Daniel Janney

Nicholas Simon

Erik Harris

Director/Board Member

Director/Board Member

Sales & Marketing

ILLUMINA, INC. Biotechnology

Jay Flatley

Helmy Eltoukhy

AmirAli Talasaz

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Vicki Sato

David Schenkein

Richard Heyman

Private Equity Analyst

Private Equity Investor

Private Equity Analyst

Biotechnology

Lodewijk J. R. de Vink

Severin Schwan

Chairman

Corporate Officer/Principal

GALAPAGOS NV Biotechnology

Vicki Sato

Peter K. M. Verhaeghe

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

John Nicols

Ian Clark

Paul Hastings

Joseph deBethizy

David Schenkein

Sara Radcliffe

Director/Board Member

Director/Board Member

Chairman

Director/Board Member

Director/Board Member

Corporate Officer/Principal

NGM BIOPHARMACEUTICALS, INC. Biotechnology

Peter Svennilson

Carole Ho

Director/Board Member

Director/Board Member

AGIOS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Ian Clark

David Schenkein

Marc Tessier-Lavigne

Director/Board Member

Chief Executive Officer

Chairman

Biotechnology

Vicki Sato

Elaine Jones

Director/Board Member

Director/Board Member

Investment Managers

Anthony Adam Rosenberg

Nicholas Simon

Private Equity Investor

Private Equity Investor

Miscellaneous Commercial Services

Andrew Allen

David B. Krieger

Corporate Officer/Principal

Corporate Officer/Principal

College/University

Vicki Sato

Werner Lanthaler

Gregory C. Farrington

Judith Li

Doctorate Degree

Graduate Degree

Doctorate Degree

Undergraduate Degree

Stanford University College/University

Jay Flatley

Richard Scheller

Thomas Woiwode

Marc Tessier-Lavigne

Jennifer Cook

Helmy Eltoukhy

AmirAli Talasaz

Ryan Watts

Graduate Degree

Corporate Officer/Principal

Doctorate Degree

President

Graduate Degree

Doctorate Degree

Doctorate Degree

Doctorate Degree

University of Oxford College/University

Andrew Allen

Marc Tessier-Lavigne

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Pascal Soriot

Björn Oskar Larsson

Chairman

Corporate Officer/Principal

Supranational

Wolfgang Ruttenstorfer

Beatrice Weder di Mauro

Chairman

Corporate Officer/Principal

Yale University College/University

Peter Moldt

Linda Grais

Peter Klein

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

University of California, Berkeley College/University

Thomas Woiwode

Kumud Kalia

Jason V. Coloma

Undergraduate Degree

Graduate Degree

Doctorate Degree

University of Maryland College/University

Nicholas Simon

Samir Kaul

Joseph deBethizy

Undergraduate Degree

Graduate Degree

Undergraduate Degree

University of Michigan College/University

Samir Kaul

Lawrence Corey

Undergraduate Degree

Doctorate Degree

Stockholm School of Economics College/University

Peter Svennilson

Anders Edvell

Masters Business Admin

Doctorate Degree

International Monetary Fund General Government

Wolfgang Ruttenstorfer

Beatrice Weder di Mauro

Chairman

Corporate Officer/Principal

London School of Economics & Political Science College/University

Musa Tariq

Ana Cespedes

Undergraduate Degree

Corporate Officer/Principal

University of Leicester College/University

Anthony Adam Rosenberg

Michael Bell

Undergraduate Degree

Undergraduate Degree

Ghent University College/University

Tim van Hauwermeiren

Peter Ulrichts

Graduate Degree

Doctorate Degree

Katholieke Universiteit Leuven College/University

Peter K. M. Verhaeghe

Peter Ulrichts

Filip Borgions

Corporate Officer/Principal

Undergraduate Degree

Doctorate Degree

Pharmaceuticals: Major

Lodewijk J. R. de Vink

Pascal Soriot

Sara Radcliffe

Chairman

Director/Board Member

Corporate Officer/Principal

Miscellaneous Commercial Services

Richard Scheller

Marc Tessier-Lavigne

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Daniel Janney

Ian Clark

Nicholas Simon

Linda Grais

Corporate Officer/Principal

Corporate Officer/Principal

Director/Board Member

Director/Board Member

FATE THERAPEUTICS, INC. Biotechnology

Karin Jooss

Shefali Agarwal

Director/Board Member

Director/Board Member

Investment Managers

Richard Scheller

Peter Svennilson

Private Equity Investor

Founder

IMMUNE DESIGN CORP Pharmaceuticals: Major

Peter Svennilson

Lawrence Corey

Director/Board Member

Founder

Biotechnology

John Nicols

Paul Hastings

Sara Radcliffe

Director/Board Member

Director/Board Member

Chief Executive Officer

JUNO THERAPEUTICS INC Biotechnology

Jay Flatley

Marc Tessier-Lavigne

Lawrence Corey

Director/Board Member

Director/Board Member

Founder

Investment Managers

Richard Scheller

David Schenkein

Nancy Thornberry

Consultant / Advisor

Private Equity Investor

Consultant / Advisor

ORIC PHARMACEUTICALS, INC. Pharmaceuticals: Major

Richard Scheller

Peter Svennilson

Richard Heyman

Director/Board Member

Chief Executive Officer

Founder

Pharmaceuticals: Major

Peter Svennilson

Richard Heyman

Chairman

Chief Executive Officer

Pharmaceuticals: Major

Peter Svennilson

Richard Heyman

Chairman

Founder

FOUNDATION MEDICINE INC Medical/Nursing Services

David Schenkein

Matthew Hawryluk

Director/Board Member

Corporate Officer/Principal

RAYZEBIO, INC. Biotechnology

Richard Heyman

Tim van Hauwermeiren

Chairman

Director/Board Member

EPIZYME, INC. Biotechnology

Andrew Allen

Shefali Agarwal

Director/Board Member

Chief Tech/Sci/R&D Officer

BRIDGEBIO PHARMA, INC. Biotechnology

Richard Scheller

Jennifer Cook

Chief Tech/Sci/R&D Officer

Director/Board Member

Statistiche

Distribuzione geografica

Stati Uniti 41
Belgio 4
Regno Unito 4
Svizzera 3
Svezia 3

Settori

Health Technology 27
Consumer Services 13
Commercial Services 6
Finance 5
Government 3

Posizioni

Director/Board Member 678
Corporate Officer/Principal 236
Independent Dir/Board Member 205
Chairman 115
Chief Executive Officer 78